The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...

Jan. 21 (UPI) --The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato has been approved to treat a ...

NEW YORK (PIX11) – A nose spray has been approved by the U.S. Food and Drug Administration to help treat depression, Johnson & Johnson announced on Tuesday. Spravato is a first-of-its-kind ...

3M's end markets remain mixed, but management has a margin expansion opportunity. CEO Bill Brown will outline his vision for the company in February. The stock looks like a good value and is a ...

3M returned $1.1 billion to shareholders via dividends and share repurchases. Cash from operations of $1.8 billion. Adjusted free cash flow of $1.3 billion.

Most products come in a hand-operated pump bottle or squeeze bottle. Knowing how to use a nasal spray is important, as doing it incorrectly could affect the dose you receive. There are many OTC and ...

As of now, 3M offers an annual dividend yield of 2.01%, which is a quarterly dividend amount of 70 cents per share ($2.80 a year). So, how can investors exploit its dividend yield to pocket a ...

The Mazda CX-80 hits the right notes for a large SUV when it comes to rear seat space in the second and third rows. Its interior offers all the versatility you’d expect, and regardless of ...

Its stock looks cheap, but it could deserve that discount valuation. 3M sells over 60,000 products, including adhesives, abrasives, laminates, fire protection products, personal protective ...